MarketWatch.com | Top Stories

Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.
favicon
marketwatch.com
marketwatch.com
Image for the article: Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up
Create attached notes ...